Table 2.
Characteristics of the left ventricular failure and healthy subjects groups
| PH (n = 53) | LVF (n = 42) | HS (n = 31) | ||
|---|---|---|---|---|
| Age (years) | 40.8 ± 16.5 | 58.6 ± 10 * | 40.5 ± 17 | |
| Females (%) | 73.6 | 28.9 * | 74.2 | |
| BMI (kg/m2) | 26.2 ± 5 | 30.9 ± 6 * | 25.2 ± 4 | |
| FC (%) | I–II | 71.2 | 86.7 | – |
| III–IV | 28.8 | 13.3 | – | |
| VitD (mg/dL) | 19.25 ± 10.1 * | 25.68 ± 12 | 28.8 ± 12 | |
| Ht (%) | 43.9 ± 8.9 | 40.9 ± 7.5 | 40.6 ± 5.3 | |
| Urea (mg/mL) | 34.49 ± 12.1 | 45.63 ± 16.3 | 33.6 ± 9.2 ** | |
| Creatinine (mg/%) | 0.96 ± 0.9 | 1.04 ± 0.6 | 0.75 ± 0.3 | |
| Sodium (mEq/Lt) | 140.4 ± 2.6 | 137.7 ± 6.2 | 140 ± 2.9 | |
| Total bilirubin (mg/dL) | 1.14 ± 1 | 0.76 ± 0.8 | 0.57 ± 0.2 # | |
| LVEF (%) | 61.9 ± 7 | 34.3 ± 10 * | 65.4 ± 8 | |
| LVDD (mm) | 43.5 ± 6 | 65.6 ± 10 * | 48.3 ± 23 | |
| LA (mm) | 35.6 ± 8 | 46.84 ± 15 * | 39.7 ± 7 | |
| SPAP (mmHg) | 81.55 ± 3 * | 43.91 ± 23 | 31.84 ± 15 ** | |
*p < 0.05 vs. rest of groups; **p < 0.05 vs LVF; #p < 0.05 vs PH